Bayer expects Roundup settlement before Christmas as litigation review nears
Bayer says it expects a $7.25 billion settlement over its Roundup weedkiller to arrive before Christmas as the company works to narrow a large U.S. litigation over cancer claims. The proposed deal is under review by a Missouri state court judge in St. Louis and would sharply reduce the number of individual cases still moving through court.
Highlights
- Bayer expects court approval of a $7.25 billion Roundup settlement before Christmas, significantly reducing the number of individual cases remaining.
- Bayer faces approximately 65,000 Roundup-related cancer claims in U.S. courts, seeking resolution through the proposed Missouri court settlement.
- Following a June Supreme Court victory, Bayer restructured its U.S. Roundup business as Ruveon and maintains glyphosate's safety based on decades of studies.
Settlement timeline and court review
As reported by Reuters, Chief Executive Bill Anderson says Bayer expects the Roundup settlement to come before Christmas and indicates the timing could fall in any week from now. He says on a press call after the company’s results that the agreement would leave a much smaller number of individual cases once approved.The German drugs and agrochemicals group is seeking to resolve tens of thousands of lawsuits through the proposed $7.25 billion settlement. The arrangement remains under review by a Missouri state court judge in St. Louis.
Litigation exposure and U.S. business changes
Bayer is facing about 65,000 claims in U.S. state and federal courts from plaintiffs who allege they developed non-Hodgkin lymphoma and other forms of cancer after using Roundup at home or at work.After a Supreme Court victory in June, Bayer moves its U.S. Roundup business into a unit called Ruveon and internally separates it from the rest of the organisation. Bayer says decades of studies show glyphosate, the active ingredient in Roundup, is safe and does not cause cancer.
Our earlier article on Chariot Claims’ $10 million Series A explained how the legal tech startup is building AI-assisted workflows to help law firms screen, process and research mass arbitration and other high-volume consumer claims. We also noted that strong funding in legal tech is accelerating automation in case intake and review—an important backdrop as major companies look for ways to streamline and contain exposure from large waves of lawsuits.
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
